315 related articles for article (PubMed ID: 26815201)
1. Activation of KCNQ channels located on the skeletal muscle membrane by retigabine and its influence on the maximal muscle force in rat muscle strips.
Zagorchev P; Apostolova E; Kokova V; Peychev L
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):439-46. PubMed ID: 26815201
[TBL] [Abstract][Full Text] [Related]
2. KV7 channels regulate muscle tone and nonadrenergic noncholinergic relaxation of the rat gastric fundus.
Ipavec V; Martire M; Barrese V; Taglialatela M; Currò D
Pharmacol Res; 2011 Oct; 64(4):397-409. PubMed ID: 21740972
[TBL] [Abstract][Full Text] [Related]
3. The pan-Kv7 (KCNQ) Channel Opener Retigabine Inhibits Striatal Excitability by Direct Action on Striatal Neurons In Vivo.
Hansen HH; Weikop P; Mikkelsen MD; Rode F; Mikkelsen JD
Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):46-51. PubMed ID: 27377794
[TBL] [Abstract][Full Text] [Related]
4. Retigabine diminishes the effects of acetylcholine, adrenaline and adrenergic agonists on the spontaneous activity of guinea pig smooth muscle strips in vitro.
Apostolova E; Zagorchev P; Kokova V; Peychev L
Auton Neurosci; 2017 Mar; 203():51-57. PubMed ID: 28041987
[TBL] [Abstract][Full Text] [Related]
5. Functional effects of the KCNQ modulators retigabine and XE991 in the rat urinary bladder.
Rode F; Svalø J; Sheykhzade M; Rønn LC
Eur J Pharmacol; 2010 Jul; 638(1-3):121-7. PubMed ID: 20385123
[TBL] [Abstract][Full Text] [Related]
6. Bimodal effects of the Kv7 channel activator retigabine on vascular K+ currents.
Yeung S; Schwake M; Pucovský V; Greenwood Ia
Br J Pharmacol; 2008 Sep; 155(1):62-72. PubMed ID: 18536747
[TBL] [Abstract][Full Text] [Related]
7. K
Bientinesi R; Mancuso C; Martire M; Bassi PF; Sacco E; Currò D
Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):127-137. PubMed ID: 27761601
[TBL] [Abstract][Full Text] [Related]
8. Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm.
Mani BK; O'Dowd J; Kumar L; Brueggemann LI; Ross M; Byron KL
J Cardiovasc Pharmacol; 2013 Jan; 61(1):51-62. PubMed ID: 23107868
[TBL] [Abstract][Full Text] [Related]
9. Kv7/KCNQ/M-channels in rat glutamatergic hippocampal axons and their role in regulation of excitability and transmitter release.
Vervaeke K; Gu N; Agdestein C; Hu H; Storm JF
J Physiol; 2006 Oct; 576(Pt 1):235-56. PubMed ID: 16840518
[TBL] [Abstract][Full Text] [Related]
10. Expression and motor functional roles of voltage-dependent type 7 K(+) channels in the human taenia coli.
Adduci A; Martire M; Taglialatela M; Arena V; Rizzo G; Coco C; Currò D
Eur J Pharmacol; 2013 Dec; 721(1-3):12-20. PubMed ID: 24120659
[TBL] [Abstract][Full Text] [Related]
11. KCNQ (Kv7) potassium channel activators as bronchodilators: combination with a β2-adrenergic agonist enhances relaxation of rat airways.
Brueggemann LI; Haick JM; Neuburg S; Tate S; Randhawa D; Cribbs LL; Byron KL
Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(6):L476-86. PubMed ID: 24441871
[TBL] [Abstract][Full Text] [Related]
12. The pharmacological effect of positive KCNQ (Kv7) modulators on dopamine release from striatal slices.
Jensen MM; Lange SC; Thomsen MS; Hansen HH; Mikkelsen JD
Basic Clin Pharmacol Toxicol; 2011 Nov; 109(5):339-42. PubMed ID: 21599837
[TBL] [Abstract][Full Text] [Related]
13. Molecular expression and pharmacological evidence for a functional role of kv7 channel subtypes in Guinea pig urinary bladder smooth muscle.
Afeli SA; Malysz J; Petkov GV
PLoS One; 2013; 8(9):e75875. PubMed ID: 24073284
[TBL] [Abstract][Full Text] [Related]
14. Activation of voltage-gated KCNQ/Kv7 channels by anticonvulsant retigabine attenuates mechanical allodynia of inflammatory temporomandibular joint in rats.
Xu W; Wu Y; Bi Y; Tan L; Gan Y; Wang K
Mol Pain; 2010 Aug; 6():49. PubMed ID: 20796319
[TBL] [Abstract][Full Text] [Related]
15. The neuronal KCNQ channel opener retigabine inhibits locomotor activity and reduces forebrain excitatory responses to the psychostimulants cocaine, methylphenidate and phencyclidine.
Hansen HH; Andreasen JT; Weikop P; Mirza N; Scheel-Krüger J; Mikkelsen JD
Eur J Pharmacol; 2007 Sep; 570(1-3):77-88. PubMed ID: 17628530
[TBL] [Abstract][Full Text] [Related]
16. Effects of novel subtype selective M-current activators on spinal reflexes in vitro: Comparison with retigabine.
Vicente-Baz J; Lopez-Garcia JA; Rivera-Arconada I
Neuropharmacology; 2016 Oct; 109():131-138. PubMed ID: 27263036
[TBL] [Abstract][Full Text] [Related]
17. The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation.
Dost R; Rostock A; Rundfeldt C
Naunyn Schmiedebergs Arch Pharmacol; 2004 Apr; 369(4):382-90. PubMed ID: 15007538
[TBL] [Abstract][Full Text] [Related]
18. Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels.
Korsgaard MP; Hartz BP; Brown WD; Ahring PK; Strøbaek D; Mirza NR
J Pharmacol Exp Ther; 2005 Jul; 314(1):282-92. PubMed ID: 15814569
[TBL] [Abstract][Full Text] [Related]
19. Activation of KCNQ Channels Suppresses Spontaneous Activity in Dorsal Root Ganglion Neurons and Reduces Chronic Pain after Spinal Cord Injury.
Wu Z; Li L; Xie F; Du J; Zuo Y; Frost JA; Carlton SM; Walters ET; Yang Q
J Neurotrauma; 2017 Mar; 34(6):1260-1270. PubMed ID: 28073317
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine.
Schenzer A; Friedrich T; Pusch M; Saftig P; Jentsch TJ; Grötzinger J; Schwake M
J Neurosci; 2005 May; 25(20):5051-60. PubMed ID: 15901787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
